Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the endocrine system (HP:0000818)help
Parent Node:
expand
Abnormality of the parathyroid gland (HP:0000828)help
..Starting node
..expand
Abnormality of the parathyroid physiology (HP:0011767)help
Term ID: 11767
Name: Abnormality of the parathyroid physiology
Synonym: Parathyroid dysfunction; Parathyroid issue
Definition: A functional abnormality of the parathyroid gland.
Comments:
Reference: HP:0011767
Genes and Diseases:
 
       Child Nodes:
........expandHypoparathyroidism (HP:0000829) help
................... HP:0008198 Congenital hypoparathyroidism
................... HP:0011771 Autoimmune hypoparathyroidism
........expandHyperparathyroidism (HP:0000843) help
................... HP:0000867 Secondary hyperparathyroidism
................... HP:0008200 Primary hyperparathyroidism
................... HP:0011770 Tertiary hyperparathyroidism
........expandPseudohypoparathyroidism (HP:0000852) help

 Sister Nodes: 
..expandAbnormality of the parathyroid morphology (HP:0011766) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0011767HP:0011767Abnormality of the parathyroid physiology0ACTG2 CL E G H72145ORPHA:2604Familial visceral myopathy23
HP:0011767HP:0011767Abnormality of the parathyroid physiology0AIRE CL E G H326360OMIM:240300AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS192
HP:0011767HP:0011767Abnormality of the parathyroid physiology0AIRE CL E G H326360ORPHA:3453Autoimmune polyendocrinopathy type 192
HP:0011767HP:0011767Abnormality of the parathyroid physiology0AP2S1 CL E G H1175565OMIM:600740Hypocalciuric hypercalcemia, familial, type III6
HP:0011767HP:0011767Abnormality of the parathyroid physiology0ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia7
HP:0011767HP:0011767Abnormality of the parathyroid physiology0ARVCF CL E G H421728ORPHA:56722q11.2 deletion syndrome1
HP:0011767HP:0011767Abnormality of the parathyroid physiology0ATP7B CL E G H540870OMIM:277900Wilson disease315
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CA2 CL E G H7601373ORPHA:2785Osteopetrosis with renal tubular acidosis29
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CASR CL E G H8461514OMIM:239200Hyperparathyroidism, neonatal severe272
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CASR CL E G H8461514OMIM:145980Hypocalciuric hypercalcemia, familial, type I272
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CDC73 CL E G H7957716783ORPHA:99879Familial isolated hyperparathyroidism169
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CDC73 CL E G H7957716783OMIM:145000Hyperparathyroidism 1169
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CDC73 CL E G H7957716783OMIM:145001Hyperparathyroidism 2169
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CDC73 CL E G H7957716783ORPHA:99880Hyperparathyroidism-jaw tumor syndrome169
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CDC73 CL E G H7957716783ORPHA:143Parathyroid carcinoma169
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CDC73 CL E G H7957716783OMIM:608266Parathyroid carcinoma169
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 12
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1102
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CDKN1B CL E G H10271785ORPHA:276152Multiple endocrine neoplasia type 4102
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CDKN1B CL E G H10271785OMIM:610755Multiple endocrine neoplasia, type IV102
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 11
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CHD7 CL E G H5563620626OMIM:214800Charge syndrome515
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CLDN10 CL E G H90712033OMIM:617671Helix syndrome3
HP:0011767HP:0011767Abnormality of the parathyroid physiology0COL4A5 CL E G H12872207OMIM:301050Alport syndrome, X-linked678
HP:0011767HP:0011767Abnormality of the parathyroid physiology0COMT CL E G H13122228ORPHA:56722q11.2 deletion syndrome6
HP:0011767HP:0011767Abnormality of the parathyroid physiology0COX1 CL E G H45127419ORPHA:550MELAS
HP:0011767HP:0011767Abnormality of the parathyroid physiology0COX2 CL E G H45137421ORPHA:550MELAS
HP:0011767HP:0011767Abnormality of the parathyroid physiology0COX3 CL E G H45147422ORPHA:550MELAS
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CYP27B1 CL E G H15942606ORPHA:289157Hypocalcemic vitamin D-dependent rickets41
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CYP27B1 CL E G H15942606OMIM:264700Vitamin D hydroxylation-deficient rickets, type 1A41
HP:0011767HP:0011767Abnormality of the parathyroid physiology0CYP2R1 CL E G H12022720580ORPHA:289157Hypocalcemic vitamin D-dependent rickets5
HP:0011767HP:0011767Abnormality of the parathyroid physiology0DGCR2 CL E G H99932845OMIM:192430Velocardiofacial syndrome
HP:0011767HP:0011767Abnormality of the parathyroid physiology0DGCR6 CL E G H82142846OMIM:192430Velocardiofacial syndrome
HP:0011767HP:0011767Abnormality of the parathyroid physiology0DGCR8 CL E G H544872847OMIM:192430Velocardiofacial syndrome
HP:0011767HP:0011767Abnormality of the parathyroid physiology0ESS2 CL E G H822016817OMIM:192430Velocardiofacial syndrome
HP:0011767HP:0011767Abnormality of the parathyroid physiology0FAM111A CL E G H6390124725ORPHA:93325Autosomal dominant Kenny-Caffey syndrome8
HP:0011767HP:0011767Abnormality of the parathyroid physiology0FAM111A CL E G H6390124725OMIM:127000Kenny-caffey syndrome, type 28
HP:0011767HP:0011767Abnormality of the parathyroid physiology0FOXI1 CL E G H22993815ORPHA:705Pendred syndrome33
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GATA3 CL E G H26254172OMIM:146255Hypoparathyroidism, sensorineural deafness, and renal dysplasia83
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GATA3 CL E G H26254172ORPHA:2237Hypoparathyroidism-sensorineural deafness-renal disease syndrome83
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GCM2 CL E G H92474198ORPHA:99879Familial isolated hyperparathyroidism51
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GCM2 CL E G H92474198ORPHA:2239Familial isolated hypoparathyroidism due to agenesis of parathyroid gland51
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GCM2 CL E G H92474198OMIM:617343Hyperparathyroidism 451
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GNA11 CL E G H27674379OMIM:145981Hypocalciuric hypercalcemia, familial, type II16
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia101
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GNAS CL E G H27784392OMIM:174800McCune-Albright syndrome, somatic, mosaic101
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GNAS CL E G H27784392ORPHA:79443Pseudohypoparathyroidism type 1A101
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GNAS CL E G H27784392ORPHA:94089Pseudohypoparathyroidism type 1B101
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GNAS CL E G H27784392ORPHA:79444Pseudohypoparathyroidism type 1C101
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GNAS CL E G H27784392OMIM:103580Pseudohypoparathyroidism, type IA101
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GNAS CL E G H27784392OMIM:603233Pseudohypoparathyroidism, type IB101
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GNAS CL E G H27784392OMIM:612462Pseudohypoparathyroidism, type IC101
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GNAS CL E G H27784392OMIM:612463PSEUDOPSEUDOHYPOPARATHYROIDISM101
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GNAS-AS1 CL E G H14977524872OMIM:603233Pseudohypoparathyroidism, type IB1
HP:0011767HP:0011767Abnormality of the parathyroid physiology0GP1BB CL E G H28124440ORPHA:56722q11.2 deletion syndrome8
HP:0011767HP:0011767Abnormality of the parathyroid physiology0HADHA CL E G H30304801ORPHA:746Mitochondrial trifunctional protein deficiency99
HP:0011767HP:0011767Abnormality of the parathyroid physiology0HADHB CL E G H30324803ORPHA:746Mitochondrial trifunctional protein deficiency60
HP:0011767HP:0011767Abnormality of the parathyroid physiology0HBB CL E G H30434827ORPHA:231222Beta-thalassemia intermedia580
HP:0011767HP:0011767Abnormality of the parathyroid physiology0HBB CL E G H30434827ORPHA:231214Beta-thalassemia major580
HP:0011767HP:0011767Abnormality of the parathyroid physiology0HBB CL E G H30434827ORPHA:231226Dominant beta-thalassemia580
HP:0011767HP:0011767Abnormality of the parathyroid physiology0HIRA CL E G H72904916ORPHA:56722q11.2 deletion syndrome3
HP:0011767HP:0011767Abnormality of the parathyroid physiology0IRX5 CL E G H1026514361OMIM:611174Hamamy syndrome4
HP:0011767HP:0011767Abnormality of the parathyroid physiology0JMJD1C CL E G H22103712313ORPHA:56722q11.2 deletion syndrome2
HP:0011767HP:0011767Abnormality of the parathyroid physiology0KCNJ10 CL E G H37666256ORPHA:705Pendred syndrome121
HP:0011767HP:0011767Abnormality of the parathyroid physiology0LIG4 CL E G H39816601ORPHA:235Dubowitz syndrome88
HP:0011767HP:0011767Abnormality of the parathyroid physiology0MEN1 CL E G H42217010ORPHA:99879Familial isolated hyperparathyroidism462
HP:0011767HP:0011767Abnormality of the parathyroid physiology0MEN1 CL E G H42217010ORPHA:97279Insulinoma462
HP:0011767HP:0011767Abnormality of the parathyroid physiology0MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1462
HP:0011767HP:0011767Abnormality of the parathyroid physiology0ND1 CL E G H45357455ORPHA:550MELAS
HP:0011767HP:0011767Abnormality of the parathyroid physiology0ND4 CL E G H45387459ORPHA:550MELAS
HP:0011767HP:0011767Abnormality of the parathyroid physiology0ND5 CL E G H45407461ORPHA:550MELAS
HP:0011767HP:0011767Abnormality of the parathyroid physiology0ND6 CL E G H45417462ORPHA:550MELAS
HP:0011767HP:0011767Abnormality of the parathyroid physiology0NKX2-1 CL E G H708011825ORPHA:209905Brain-lung-thyroid syndrome51
HP:0011767HP:0011767Abnormality of the parathyroid physiology0NSUN2 CL E G H5488825994ORPHA:235Dubowitz syndrome84
HP:0011767HP:0011767Abnormality of the parathyroid physiology0OCRL CL E G H49528108ORPHA:534Oculocerebrorenal syndrome of Lowe88
HP:0011767HP:0011767Abnormality of the parathyroid physiology0PDE4D CL E G H51448783ORPHA:280651Acrodysostosis with multiple hormone resistance113
HP:0011767HP:0011767Abnormality of the parathyroid physiology0PIGT CL E G H5160414938ORPHA:369837Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome12
HP:0011767HP:0011767Abnormality of the parathyroid physiology0PLEKHM1 CL E G H984229017OMIM:618107OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA32
HP:0011767HP:0011767Abnormality of the parathyroid physiology0PRKAR1A CL E G H55739388ORPHA:280651Acrodysostosis with multiple hormone resistance134
HP:0011767HP:0011767Abnormality of the parathyroid physiology0PRMT7 CL E G H5449625557OMIM:617157Short stature, brachydactyly, intellectual developmental disability, and seizures6
HP:0011767HP:0011767Abnormality of the parathyroid physiology0PRMT7 CL E G H5449625557ORPHA:464288Short stature-brachydactyly-obesity-global developmental delay syndrome6
HP:0011767HP:0011767Abnormality of the parathyroid physiology0PTH CL E G H57419606OMIM:146200Hypoparathyroidism, familial isolated16
HP:0011767HP:0011767Abnormality of the parathyroid physiology0PTH1R CL E G H57459608OMIM:156400Metaphyseal chondrodysplasia, Jansen type58
HP:0011767HP:0011767Abnormality of the parathyroid physiology0RET CL E G H59799967OMIM:171400Multiple endocrine neoplasia, type IIA572
HP:0011767HP:0011767Abnormality of the parathyroid physiology0RREB1 CL E G H623910449ORPHA:56722q11.2 deletion syndrome
HP:0011767HP:0011767Abnormality of the parathyroid physiology0SEC24C CL E G H963210705ORPHA:56722q11.2 deletion syndrome
HP:0011767HP:0011767Abnormality of the parathyroid physiology0SLC12A1 CL E G H655710910OMIM:601678Bartter syndrome, type 1, antenatal75
HP:0011767HP:0011767Abnormality of the parathyroid physiology0SLC26A4 CL E G H51728818ORPHA:705Pendred syndrome274
HP:0011767HP:0011767Abnormality of the parathyroid physiology0STX16 CL E G H867511431ORPHA:94089Pseudohypoparathyroidism type 1B86
HP:0011767HP:0011767Abnormality of the parathyroid physiology0STX16 CL E G H867511431OMIM:603233Pseudohypoparathyroidism, type IB86
HP:0011767HP:0011767Abnormality of the parathyroid physiology0TBCE CL E G H690511582ORPHA:93324Autosomal recessive Kenny-Caffey syndrome52
HP:0011767HP:0011767Abnormality of the parathyroid physiology0TBCE CL E G H690511582OMIM:241410Hypoparathyroidism-Retardation-Dysmorphism syndrome52
HP:0011767HP:0011767Abnormality of the parathyroid physiology0TBCE CL E G H690511582OMIM:244460Kenny-caffey syndrome, type 152
HP:0011767HP:0011767Abnormality of the parathyroid physiology0TBCE CL E G H690511582ORPHA:2323Sanjad-Sakati syndrome52
HP:0011767HP:0011767Abnormality of the parathyroid physiology0TBX1 CL E G H689911592ORPHA:56722q11.2 deletion syndrome32
HP:0011767HP:0011767Abnormality of the parathyroid physiology0TBX1 CL E G H689911592OMIM:192430Velocardiofacial syndrome32
HP:0011767HP:0011767Abnormality of the parathyroid physiology0TBX2 CL E G H690911597OMIM:618223VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION
HP:0011767HP:0011767Abnormality of the parathyroid physiology0TRNF CL E G H45587481ORPHA:550MELAS
HP:0011767HP:0011767Abnormality of the parathyroid physiology0TRNH CL E G H45647487ORPHA:550MELAS
HP:0011767HP:0011767Abnormality of the parathyroid physiology0TRNL1 CL E G H45677490ORPHA:550MELAS
HP:0011767HP:0011767Abnormality of the parathyroid physiology0TRNQ CL E G H45727495ORPHA:550MELAS
HP:0011767HP:0011767Abnormality of the parathyroid physiology0TRNS1 CL E G H45747497ORPHA:550MELAS
HP:0011767HP:0011767Abnormality of the parathyroid physiology0TRNS2 CL E G H45757498ORPHA:550MELAS
HP:0011767HP:0011767Abnormality of the parathyroid physiology0TRNW CL E G H45787501ORPHA:550MELAS
HP:0011767HP:0011767Abnormality of the parathyroid physiology0UFD1 CL E G H735312520ORPHA:56722q11.2 deletion syndrome
HP:0011767HP:0011767Abnormality of the parathyroid physiology0VDR CL E G H742112679ORPHA:93160Hypocalcemic vitamin D-resistant rickets104
HP:0011767HP:0011767Abnormality of the parathyroid physiology0VDR CL E G H742112679OMIM:277440Vitamin d-dependent rickets, type 2A104
HP:0011767HP:0011767Abnormality of the parathyroid physiology0YY1 CL E G H752812856ORPHA:97279Insulinoma7
HP:0011767HP:0000843Hyperparathyroidism1ACTG2 CL E G H72145ORPHA:2604Familial visceral myopathyHP:0040283 - Occasional23
HP:0011767HP:0000829Hypoparathyroidism1AIRE CL E G H326360OMIM:240300AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS192
HP:0011767HP:0000829Hypoparathyroidism1AIRE CL E G H326360ORPHA:3453Autoimmune polyendocrinopathy type 1HP:0040281 - Very frequent92
HP:0011767HP:0000843Hyperparathyroidism1AP2S1 CL E G H1175565OMIM:600740Hypocalciuric hypercalcemia, familial, type III6
HP:0011767HP:0000843Hyperparathyroidism1ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia7
HP:0011767HP:0000829Hypoparathyroidism1ARVCF CL E G H421728ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent1
HP:0011767HP:0000829Hypoparathyroidism1ATP7B CL E G H540870OMIM:277900Wilson disease.315
HP:0011767HP:0000843Hyperparathyroidism1CA2 CL E G H7601373ORPHA:2785Osteopetrosis with renal tubular acidosis29
HP:0011767HP:0000843Hyperparathyroidism1CASR CL E G H8461514OMIM:239200Hyperparathyroidism, neonatal severe272
HP:0011767HP:0000843Hyperparathyroidism1CASR CL E G H8461514OMIM:145980Hypocalciuric hypercalcemia, familial, type I.272
HP:0011767HP:0000843Hyperparathyroidism1CDC73 CL E G H7957716783ORPHA:99879Familial isolated hyperparathyroidism169
HP:0011767HP:0000843Hyperparathyroidism1CDC73 CL E G H7957716783OMIM:145000Hyperparathyroidism 1169
HP:0011767HP:0000843Hyperparathyroidism1CDC73 CL E G H7957716783OMIM:145001Hyperparathyroidism 2.169
HP:0011767HP:0000843Hyperparathyroidism1CDC73 CL E G H7957716783ORPHA:99880Hyperparathyroidism-jaw tumor syndrome169
HP:0011767HP:0000843Hyperparathyroidism1CDC73 CL E G H7957716783OMIM:608266Parathyroid carcinoma.169
HP:0011767HP:0000843Hyperparathyroidism1CDC73 CL E G H7957716783ORPHA:143Parathyroid carcinoma169
HP:0011767HP:0000843Hyperparathyroidism1CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 12
HP:0011767HP:0000843Hyperparathyroidism1CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1102
HP:0011767HP:0000843Hyperparathyroidism1CDKN1B CL E G H10271785ORPHA:276152Multiple endocrine neoplasia type 4HP:0040281 - Very frequent102
HP:0011767HP:0000843Hyperparathyroidism1CDKN1B CL E G H10271785OMIM:610755Multiple endocrine neoplasia, type IV102
HP:0011767HP:0000843Hyperparathyroidism1CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 11
HP:0011767HP:0000843Hyperparathyroidism1CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1
HP:0011767HP:0000829Hypoparathyroidism1CHD7 CL E G H5563620626OMIM:214800Charge syndrome515
HP:0011767HP:0000843Hyperparathyroidism1CLDN10 CL E G H90712033OMIM:617671Helix syndrome3
HP:0011767HP:0000829Hypoparathyroidism1COL4A5 CL E G H12872207OMIM:301050Alport syndrome, X-linked.678
HP:0011767HP:0000829Hypoparathyroidism1COMT CL E G H13122228ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent6
HP:0011767HP:0000829Hypoparathyroidism1COX1 CL E G H45127419ORPHA:550MELASHP:0040284 - Very rare
HP:0011767HP:0000829Hypoparathyroidism1COX2 CL E G H45137421ORPHA:550MELASHP:0040284 - Very rare
HP:0011767HP:0000829Hypoparathyroidism1COX3 CL E G H45147422ORPHA:550MELASHP:0040284 - Very rare
HP:0011767HP:0000843Hyperparathyroidism1CYP27B1 CL E G H15942606ORPHA:289157Hypocalcemic vitamin D-dependent rickets41
HP:0011767HP:0000843Hyperparathyroidism1CYP27B1 CL E G H15942606OMIM:264700Vitamin D hydroxylation-deficient rickets, type 1A41
HP:0011767HP:0000843Hyperparathyroidism1CYP2R1 CL E G H12022720580ORPHA:289157Hypocalcemic vitamin D-dependent rickets5
HP:0011767HP:0000829Hypoparathyroidism1DGCR2 CL E G H99932845OMIM:192430Velocardiofacial syndrome
HP:0011767HP:0000829Hypoparathyroidism1DGCR6 CL E G H82142846OMIM:192430Velocardiofacial syndrome
HP:0011767HP:0000829Hypoparathyroidism1DGCR8 CL E G H544872847OMIM:192430Velocardiofacial syndrome
HP:0011767HP:0000829Hypoparathyroidism1ESS2 CL E G H822016817OMIM:192430Velocardiofacial syndrome
HP:0011767HP:0000829Hypoparathyroidism1FAM111A CL E G H6390124725ORPHA:93325Autosomal dominant Kenny-Caffey syndrome8
HP:0011767HP:0000829Hypoparathyroidism1FAM111A CL E G H6390124725OMIM:127000Kenny-caffey syndrome, type 2.8
HP:0011767HP:0000843Hyperparathyroidism1FOXI1 CL E G H22993815ORPHA:705Pendred syndromeHP:0040283 - Occasional33
HP:0011767HP:0000829Hypoparathyroidism1GATA3 CL E G H26254172OMIM:146255Hypoparathyroidism, sensorineural deafness, and renal dysplasia83
HP:0011767HP:0000829Hypoparathyroidism1GATA3 CL E G H26254172ORPHA:2237Hypoparathyroidism-sensorineural deafness-renal disease syndromeHP:0040280 - Obligate83
HP:0011767HP:0000843Hyperparathyroidism1GCM2 CL E G H92474198ORPHA:99879Familial isolated hyperparathyroidism51
HP:0011767HP:0000829Hypoparathyroidism1GCM2 CL E G H92474198ORPHA:2239Familial isolated hypoparathyroidism due to agenesis of parathyroid gland51
HP:0011767HP:0000843Hyperparathyroidism1GCM2 CL E G H92474198OMIM:617343Hyperparathyroidism 451
HP:0011767HP:0000843Hyperparathyroidism1GNA11 CL E G H27674379OMIM:145981Hypocalciuric hypercalcemia, familial, type II16
HP:0011767HP:0000843Hyperparathyroidism1GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia101
HP:0011767HP:0000843Hyperparathyroidism1GNAS CL E G H27784392OMIM:174800McCune-Albright syndrome, somatic, mosaic.101
HP:0011767HP:0000852Pseudohypoparathyroidism1GNAS CL E G H27784392ORPHA:79443Pseudohypoparathyroidism type 1AHP:0040280 - Obligate101
HP:0011767HP:0000852Pseudohypoparathyroidism1GNAS CL E G H27784392ORPHA:94089Pseudohypoparathyroidism type 1BHP:0040280 - Obligate101
HP:0011767HP:0000852Pseudohypoparathyroidism1GNAS CL E G H27784392ORPHA:79444Pseudohypoparathyroidism type 1CHP:0040280 - Obligate101
HP:0011767HP:0000852Pseudohypoparathyroidism1GNAS CL E G H27784392OMIM:103580Pseudohypoparathyroidism, type IA.101
HP:0011767HP:0000852Pseudohypoparathyroidism1GNAS CL E G H27784392OMIM:603233Pseudohypoparathyroidism, type IB.101
HP:0011767HP:0000852Pseudohypoparathyroidism1GNAS CL E G H27784392OMIM:612462Pseudohypoparathyroidism, type IC.101
HP:0011767HP:0000852Pseudohypoparathyroidism1GNAS CL E G H27784392OMIM:612463PSEUDOPSEUDOHYPOPARATHYROIDISM.101
HP:0011767HP:0000852Pseudohypoparathyroidism1GNAS-AS1 CL E G H14977524872OMIM:603233Pseudohypoparathyroidism, type IB.1
HP:0011767HP:0000829Hypoparathyroidism1GP1BB CL E G H28124440ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent8
HP:0011767HP:0000829Hypoparathyroidism1HADHA CL E G H30304801ORPHA:746Mitochondrial trifunctional protein deficiencyHP:0040283 - Occasional99
HP:0011767HP:0000829Hypoparathyroidism1HADHB CL E G H30324803ORPHA:746Mitochondrial trifunctional protein deficiencyHP:0040283 - Occasional60
HP:0011767HP:0000829Hypoparathyroidism1HBB CL E G H30434827ORPHA:231222Beta-thalassemia intermediaHP:0040284 - Very rare580
HP:0011767HP:0000829Hypoparathyroidism1HBB CL E G H30434827ORPHA:231214Beta-thalassemia majorHP:0040283 - Occasional580
HP:0011767HP:0000829Hypoparathyroidism1HBB CL E G H30434827ORPHA:231226Dominant beta-thalassemiaHP:0040283 - Occasional580
HP:0011767HP:0000829Hypoparathyroidism1HIRA CL E G H72904916ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent3
HP:0011767HP:0000829Hypoparathyroidism1IRX5 CL E G H1026514361OMIM:611174Hamamy syndrome.4
HP:0011767HP:0000829Hypoparathyroidism1JMJD1C CL E G H22103712313ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent2
HP:0011767HP:0000843Hyperparathyroidism1KCNJ10 CL E G H37666256ORPHA:705Pendred syndromeHP:0040283 - Occasional121
HP:0011767HP:0000829Hypoparathyroidism1LIG4 CL E G H39816601ORPHA:235Dubowitz syndromeHP:0040283 - Occasional88
HP:0011767HP:0000843Hyperparathyroidism1MEN1 CL E G H42217010ORPHA:99879Familial isolated hyperparathyroidism462
HP:0011767HP:0000843Hyperparathyroidism1MEN1 CL E G H42217010ORPHA:97279Insulinoma462
HP:0011767HP:0000843Hyperparathyroidism1MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1462
HP:0011767HP:0000829Hypoparathyroidism1ND1 CL E G H45357455ORPHA:550MELASHP:0040284 - Very rare
HP:0011767HP:0000829Hypoparathyroidism1ND4 CL E G H45387459ORPHA:550MELASHP:0040284 - Very rare
HP:0011767HP:0000829Hypoparathyroidism1ND5 CL E G H45407461ORPHA:550MELASHP:0040284 - Very rare
HP:0011767HP:0000829Hypoparathyroidism1ND6 CL E G H45417462ORPHA:550MELASHP:0040284 - Very rare
HP:0011767HP:0000829Hypoparathyroidism1NKX2-1 CL E G H708011825ORPHA:209905Brain-lung-thyroid syndromeHP:0040284 - Very rare51
HP:0011767HP:0000829Hypoparathyroidism1NSUN2 CL E G H5488825994ORPHA:235Dubowitz syndromeHP:0040283 - Occasional84
HP:0011767HP:0000843Hyperparathyroidism1OCRL CL E G H49528108ORPHA:534Oculocerebrorenal syndrome of LoweHP:0040282 - Frequent88
HP:0011767HP:0000852Pseudohypoparathyroidism1PDE4D CL E G H51448783ORPHA:280651Acrodysostosis with multiple hormone resistanceHP:0040280 - Obligate113
HP:0011767HP:0000829Hypoparathyroidism1PIGT CL E G H5160414938ORPHA:369837Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndromeHP:0040283 - Occasional12
HP:0011767HP:0000843Hyperparathyroidism1PLEKHM1 CL E G H984229017OMIM:618107OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA32
HP:0011767HP:0000852Pseudohypoparathyroidism1PRKAR1A CL E G H55739388ORPHA:280651Acrodysostosis with multiple hormone resistanceHP:0040280 - Obligate134
HP:0011767HP:0000852Pseudohypoparathyroidism1PRMT7 CL E G H5449625557OMIM:617157Short stature, brachydactyly, intellectual developmental disability, and seizures.6
HP:0011767HP:0000852Pseudohypoparathyroidism1PRMT7 CL E G H5449625557ORPHA:464288Short stature-brachydactyly-obesity-global developmental delay syndromeHP:0040283 - Occasional6
HP:0011767HP:0000829Hypoparathyroidism1PTH CL E G H57419606OMIM:146200Hypoparathyroidism, familial isolated16
HP:0011767HP:0000829Hypoparathyroidism1PTH1R CL E G H57459608OMIM:156400Metaphyseal chondrodysplasia, Jansen type.58
HP:0011767HP:0000843Hyperparathyroidism1RET CL E G H59799967OMIM:171400Multiple endocrine neoplasia, type IIA572
HP:0011767HP:0000829Hypoparathyroidism1RREB1 CL E G H623910449ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent
HP:0011767HP:0000829Hypoparathyroidism1SEC24C CL E G H963210705ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent
HP:0011767HP:0000843Hyperparathyroidism1SLC12A1 CL E G H655710910OMIM:601678Bartter syndrome, type 1, antenatalHP:0040283 - Occasional75
HP:0011767HP:0000843Hyperparathyroidism1SLC26A4 CL E G H51728818ORPHA:705Pendred syndromeHP:0040283 - Occasional274
HP:0011767HP:0000852Pseudohypoparathyroidism1STX16 CL E G H867511431ORPHA:94089Pseudohypoparathyroidism type 1BHP:0040280 - Obligate86
HP:0011767HP:0000852Pseudohypoparathyroidism1STX16 CL E G H867511431OMIM:603233Pseudohypoparathyroidism, type IB.86
HP:0011767HP:0000829Hypoparathyroidism1TBCE CL E G H690511582ORPHA:93324Autosomal recessive Kenny-Caffey syndrome52
HP:0011767HP:0000829Hypoparathyroidism1TBCE CL E G H690511582OMIM:241410Hypoparathyroidism-Retardation-Dysmorphism syndrome52
HP:0011767HP:0000829Hypoparathyroidism1TBCE CL E G H690511582OMIM:244460Kenny-caffey syndrome, type 152
HP:0011767HP:0000829Hypoparathyroidism1TBCE CL E G H690511582ORPHA:2323Sanjad-Sakati syndromeHP:0040281 - Very frequent52
HP:0011767HP:0000829Hypoparathyroidism1TBX1 CL E G H689911592ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent32
HP:0011767HP:0000829Hypoparathyroidism1TBX1 CL E G H689911592OMIM:192430Velocardiofacial syndrome32
HP:0011767HP:0000829Hypoparathyroidism1TBX2 CL E G H690911597OMIM:618223VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION.
HP:0011767HP:0000829Hypoparathyroidism1TRNF CL E G H45587481ORPHA:550MELASHP:0040284 - Very rare
HP:0011767HP:0000829Hypoparathyroidism1TRNH CL E G H45647487ORPHA:550MELASHP:0040284 - Very rare
HP:0011767HP:0000829Hypoparathyroidism1TRNL1 CL E G H45677490ORPHA:550MELASHP:0040284 - Very rare
HP:0011767HP:0000829Hypoparathyroidism1TRNQ CL E G H45727495ORPHA:550MELASHP:0040284 - Very rare
HP:0011767HP:0000829Hypoparathyroidism1TRNS1 CL E G H45747497ORPHA:550MELASHP:0040284 - Very rare
HP:0011767HP:0000829Hypoparathyroidism1TRNS2 CL E G H45757498ORPHA:550MELASHP:0040284 - Very rare
HP:0011767HP:0000829Hypoparathyroidism1TRNW CL E G H45787501ORPHA:550MELASHP:0040284 - Very rare
HP:0011767HP:0000829Hypoparathyroidism1UFD1 CL E G H735312520ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent
HP:0011767HP:0000843Hyperparathyroidism1VDR CL E G H742112679ORPHA:93160Hypocalcemic vitamin D-resistant ricketsHP:0040281 - Very frequent104
HP:0011767HP:0000843Hyperparathyroidism1VDR CL E G H742112679OMIM:277440Vitamin d-dependent rickets, type 2A104
HP:0011767HP:0000843Hyperparathyroidism1YY1 CL E G H752812856ORPHA:97279Insulinoma7
HP:0011767HP:0011771Autoimmune hypoparathyroidism2 CL E G H
HP:0011767HP:0011770Tertiary hyperparathyroidism2 CL E G H
HP:0011767HP:0008200Primary hyperparathyroidism2AP2S1 CL E G H1175565OMIM:600740Hypocalciuric hypercalcemia, familial, type III.6
HP:0011767HP:0008200Primary hyperparathyroidism2ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia7
HP:0011767HP:0000867Secondary hyperparathyroidism2CA2 CL E G H7601373ORPHA:2785Osteopetrosis with renal tubular acidosis29
HP:0011767HP:0008200Primary hyperparathyroidism2CASR CL E G H8461514OMIM:239200Hyperparathyroidism, neonatal severe.272
HP:0011767HP:0008200Primary hyperparathyroidism2CDC73 CL E G H7957716783ORPHA:99879Familial isolated hyperparathyroidismHP:0040281 - Very frequent169
HP:0011767HP:0008200Primary hyperparathyroidism2CDC73 CL E G H7957716783OMIM:145000Hyperparathyroidism 1.169
HP:0011767HP:0008200Primary hyperparathyroidism2CDC73 CL E G H7957716783ORPHA:99880Hyperparathyroidism-jaw tumor syndromeHP:0040280 - Obligate169
HP:0011767HP:0008200Primary hyperparathyroidism2CDC73 CL E G H7957716783ORPHA:143Parathyroid carcinomaHP:0040280 - Obligate169
HP:0011767HP:0008200Primary hyperparathyroidism2CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 1HP:0040281 - Very frequent2
HP:0011767HP:0008200Primary hyperparathyroidism2CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1HP:0040281 - Very frequent102
HP:0011767HP:0008200Primary hyperparathyroidism2CDKN1B CL E G H10271785OMIM:610755Multiple endocrine neoplasia, type IV102
HP:0011767HP:0008200Primary hyperparathyroidism2CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 1HP:0040281 - Very frequent1
HP:0011767HP:0008200Primary hyperparathyroidism2CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1HP:0040281 - Very frequent
HP:0011767HP:0000867Secondary hyperparathyroidism2CYP27B1 CL E G H15942606ORPHA:289157Hypocalcemic vitamin D-dependent ricketsHP:0040281 - Very frequent41
HP:0011767HP:0000867Secondary hyperparathyroidism2CYP27B1 CL E G H15942606OMIM:264700Vitamin D hydroxylation-deficient rickets, type 1A.41
HP:0011767HP:0000867Secondary hyperparathyroidism2CYP2R1 CL E G H12022720580ORPHA:289157Hypocalcemic vitamin D-dependent ricketsHP:0040281 - Very frequent5
HP:0011767HP:0008198Congenital hypoparathyroidism2FAM111A CL E G H6390124725ORPHA:93325Autosomal dominant Kenny-Caffey syndromeHP:0040282 - Frequent8
HP:0011767HP:0008200Primary hyperparathyroidism2GCM2 CL E G H92474198ORPHA:99879Familial isolated hyperparathyroidismHP:0040281 - Very frequent51
HP:0011767HP:0008198Congenital hypoparathyroidism2GCM2 CL E G H92474198ORPHA:2239Familial isolated hypoparathyroidism due to agenesis of parathyroid glandHP:0040280 - Obligate51
HP:0011767HP:0008200Primary hyperparathyroidism2GCM2 CL E G H92474198OMIM:617343Hyperparathyroidism 4.51
HP:0011767HP:0008200Primary hyperparathyroidism2GNA11 CL E G H27674379OMIM:145981Hypocalciuric hypercalcemia, familial, type II.16
HP:0011767HP:0008200Primary hyperparathyroidism2GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia101
HP:0011767HP:0008200Primary hyperparathyroidism2MEN1 CL E G H42217010ORPHA:99879Familial isolated hyperparathyroidismHP:0040281 - Very frequent462
HP:0011767HP:0008200Primary hyperparathyroidism2MEN1 CL E G H42217010ORPHA:97279InsulinomaHP:0040282 - Frequent462
HP:0011767HP:0008200Primary hyperparathyroidism2MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1HP:0040281 - Very frequent462
HP:0011767HP:0008198Congenital hypoparathyroidism2TBCE CL E G H690511582ORPHA:93324Autosomal recessive Kenny-Caffey syndromeHP:0040281 - Very frequent52
HP:0011767HP:0008198Congenital hypoparathyroidism2TBCE CL E G H690511582OMIM:241410Hypoparathyroidism-Retardation-Dysmorphism syndrome.52
HP:0011767HP:0008198Congenital hypoparathyroidism2TBCE CL E G H690511582OMIM:244460Kenny-caffey syndrome, type 1.52
HP:0011767HP:0008198Congenital hypoparathyroidism2TBCE CL E G H690511582ORPHA:2323Sanjad-Sakati syndromeHP:0040281 - Very frequent52
HP:0011767HP:0000867Secondary hyperparathyroidism2VDR CL E G H742112679OMIM:277440Vitamin d-dependent rickets, type 2A.104
HP:0011767HP:0008200Primary hyperparathyroidism2YY1 CL E G H752812856ORPHA:97279InsulinomaHP:0040282 - Frequent7


Genes (76) :ACTG2 AIRE AP2S1 ARMC5 ARVCF ATP7B CA2 CASR CDC73 CDKN1A CDKN1B CDKN2B CDKN2C CHD7 CLDN10 COL4A5 COMT COX1 COX2 COX3 CYP27B1 CYP2R1 DGCR2 DGCR6 DGCR8 ESS2 FAM111A FOXI1 GATA3 GCM2 GNA11 GNAS GNAS-AS1 GP1BB HADHA HADHB HBB HIRA IRX5 JMJD1C KCNJ10 LIG4 MEN1 ND1 ND4 ND5 ND6 NKX2-1 NSUN2 OCRL PDE4D PIGT PLEKHM1 PRKAR1A PRMT7 PTH PTH1R RET RREB1 SEC24C SLC12A1 SLC26A4 STX16 TBCE TBX1 TBX2 TRNF TRNH TRNL1 TRNQ TRNS1 TRNS2 TRNW UFD1 VDR YY1

Diseases (67) :ORPHA:2604 OMIM:240300 ORPHA:3453 OMIM:600740 ORPHA:189427 ORPHA:567 OMIM:277900 ORPHA:2785 OMIM:239200 OMIM:145980 ORPHA:99879 OMIM:145000 OMIM:145001 ORPHA:99880 ORPHA:143 OMIM:608266 ORPHA:652 ORPHA:276152 OMIM:610755 OMIM:214800 OMIM:617671 OMIM:301050 ORPHA:550 ORPHA:289157 OMIM:264700 OMIM:192430 ORPHA:93325 OMIM:127000 ORPHA:705 OMIM:146255 ORPHA:2237 ORPHA:2239 OMIM:617343 OMIM:145981 OMIM:174800 ORPHA:79443 ORPHA:94089 ORPHA:79444 OMIM:103580 OMIM:603233 OMIM:612462 OMIM:612463 ORPHA:746 ORPHA:231222 ORPHA:231214 ORPHA:231226 OMIM:611174 ORPHA:235 ORPHA:97279 ORPHA:209905 ORPHA:534 ORPHA:280651 ORPHA:369837 OMIM:618107 OMIM:617157 ORPHA:464288 OMIM:146200 OMIM:156400 OMIM:171400 OMIM:601678 ORPHA:93324 OMIM:241410 OMIM:244460 ORPHA:2323 OMIM:618223 ORPHA:93160 OMIM:277440
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.